Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02302196 · ClinicalTrials.gov registry record
Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects
A clinical trial, sponsored by Kaiser Permanente.
- Completed
- Registry status
- 27
- Enrollment target
NCT02302196 is a clinical trial that has completed, run by Kaiser Permanente. The registered enrollment target is 27 participants.
The verdict
NCT02302196 has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the safety and efficacy of breast reconstruction using Autologous Fat Grafting (AFG) for women post lumpectomy that have contour defects. The study hypothesis is that AFG has emerged as a less invasive alternative to breast reconstruction post mastectomy. AFG could be used to treat breast contour defects with much less invasive outpatient surgery, using the patient's own cells and tissues, which overall reduces risk.
Interventions
- OTHER Control Arm
- PROCEDURE Autologous Fat Grafting of the Breast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2015-09 |
| Est. Completion | 2021-07-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02302196
The ClinicalTrials.gov registry entry for NCT02302196 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Arm is the first listed.
NCT02302196 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02302196 about?
NCT02302196 is a clinical study titled "Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects". The purpose of the study is to evaluate the safety and efficacy of breast reconstruction using Autologous Fat Grafting (AFG) for women post lumpectomy that have contour defects. The study hypothesis is that AFG has emerged as a less invasive alternative to breast reconstruction post mastectomy. AFG...
What is the current status of trial NCT02302196?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2015-09. Estimated completion is 2021-07-13.
What interventions are being tested in trial NCT02302196?
The interventions under investigation include: Control Arm (OTHER), Autologous Fat Grafting of the Breast (PROCEDURE).
Who is sponsoring clinical trial NCT02302196?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.